Oncolytic viruses for the treatment of neoplasms having activated PP2A or Rac
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Jul 6, 2004
filing date -
Jul 7, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Methods for treating neoplasms, by administering oncolytic viruses to a neoplasm having activated PP2A-like or Rac activities, are disclosed. The virus is administered so that it ultimately directly contacts target cancer cells. Combinations of more than one type and/or strain of oncolytic viruses can be used. Of particular interest is the use of reovirus.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully